Home › Funds › Squadron Capital Management LLC › ALXO
Squadron Capital Management LLC position in ALXO
ALX ONCOLOGY HLDGS INC · Health Care
Squadron Capital Management LLC reported holding 1,400,000 shares of ALXO (ALX ONCOLOGY HLDGS INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.77% of its reported portfolio and ranking #33 among its reported holdings. Squadron Capital Management LLC has disclosed ALXO holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's ALXO position evolved
Squadron Capital Management LLC first disclosed a stake in ALXO in Q1 2026 at 1,460,000 shares (US$2.9M). Across 2 filings, Squadron Capital Management LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,400,000 shares valued at US$1.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.46M | $2.93M | New |
| Q3 2026 | 1.40M | $1.95M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALXO and 13F data
ALXO (ALX ONCOLOGY HLDGS INC) is a Health Care company. 32 other funds we track also report a position in ALXO — the largest reported positions include venBio Partners LLC (US$17.9M), Redmile Group, LLC (US$10.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$9.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALXO
- venBio Partners LLC 12.88M sh · $17.91M · Q3 2026
- Redmile Group, LLC 7.19M sh · $9.99M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 6.57M sh · $9.13M · Q3 2026
- Almitas Capital LLC 2.94M sh · $6.08M · Q2 2026
- 5AM Venture Management, LLC 3.06M sh · $4.25M · Q3 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held ALXO?
Squadron Capital Management LLC has disclosed ALXO holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Squadron Capital Management LLC's current position in ALXO?
As of Q3 2026, Squadron Capital Management LLC holds 1.40M shares of ALXO (ALX ONCOLOGY HLDGS INC), valued at $1.95M, representing 0.77% of its reported portfolio and ranking #33.
Has Squadron Capital Management LLC been buying or selling ALXO?
In the latest 13F filing (Q3 2026), Squadron Capital Management LLC newly opened its position in ALXO.
Which other funds hold ALXO?
Other major institutional holders of ALXO include venBio Partners LLC, Redmile Group, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.